New Key Statistics Module, Z-Score and F-Score
SZSE:301520 Key Ratios
Market Cap ¥ M | 2,844.67 |
Enterprise Value ¥ M | 1,688.36 |
P/E(ttm) | 26.34 |
PE Ratio without NRI | 31.17 |
Forward PE Ratio | -- |
Price/Book | 1.89 |
Price/Sales | 7.19 |
Price/Free Cash Flow | 21,335.00 |
Price/Owner Earnings | 33.97 |
Payout Ratio % | 0.37 |
Revenue (TTM) ¥ M | 394.00 |
EPS (TTM) ¥ | 1.62 |
Beneish M-Score | -1.88 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 27.80 |
y-y EBITDA Growth Rate % | -25.30 |
EV-to-EBIT | 14.34 |
EV-to-EBITDA | 14.34 |
PEG | 1.12 |
Shares Outstanding M | 66.67 |
Net Margin (%) | 27.53 |
Operating Margin % | 22.16 |
Pre-tax Margin (%) | 29.85 |
Quick Ratio | 19.39 |
Current Ratio | 19.40 |
ROA % (ttm) | 6.96 |
ROE % (ttm) | 7.35 |
ROIC % (ttm) | 22.76 |
Dividend Yield % | 1.17 |
Altman Z-Score | 20.17 |
SZSE:301520 Number of Guru Trades
SZSE:301520 Volume of Guru Trades
Gurus Latest Trades with SZSE:301520
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301520 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Anhui Wanbang Pharmaceutical Technology Co Ltd Insider Transactions
No Available Data